Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Date of authorisation: 15/06/2011, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Phelinun, melphalan, Date of authorisation: 16/11/2020, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 21, Status: Authorised

Medicine evaluation figures

Medicinal products for human use: monthly figures - May 2025

Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised

Fourth European Medicines Agency and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 1 July 2025

Human medicines European public assessment report (EPAR): Aripiprazole Zentiva, aripiprazole, Date of authorisation: 25/06/2015, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised